A phase 3 trial of a PD-1/VEGF bispecific antibody (PF‑08634404) vs pembrolizumab in combination with platinum-based chemotherapy in first-line for locally advanced or metastatic non-small cell lung cancer (Symbiotic-Lung-01)
Web preview is not available
Try directly downloading the file.